Drug development model 'must be replaced'
The development of new drugs, rooted within the pharmaceutical industry, is inefficient and unsustainable and a new model is needed to reduce the cost of medicines and improve access to them.
Archives for February 19, 2004
'Unnatural' natural products a source of new drugs
Researchers in the US have developed a way of making synthetic polyketides - structures which form the backbone of a number of drugs for cancer and infectious diseases - that could provide a new route to the design of new medicines.
Accenture to orchestrate RFID studies
Management consultancy firm Accenture has formed a group of industry leaders that will work together to evaluate the potential of new radio frequency identification (RFID) technology to improve pharmaceutical product manufacturing, distribution and...
Cardinal drops plans for Irish plant
Cardinal Health has said that it will not be proceeding with a $100 million (€78m) information technology and manufacturing facility in Longford, Ireland.
UK packaging firm Jaycare sold to VC group
UK pharmaceutical packaging firm Jaycare has been sold to venture capitalists for the second time in four years, in a deal worth more than £45 million (€67m).
FDA sees big role for RFID in drug counterfeiting war
The US Food and Drug Administration issued its final report on ways to combat pharmaceutical counterfeiting and identifies radiofrequency identification (RFID) as a primary means of tackling the problem.